Zacks Investment Management grew its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 6.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,427,638 shares of the real estate investment trust's stock after purchasing an additional 86,501 shares during the quarter. Zacks Investment Management owned 0.20% of Healthpeak Properties worth $28,938,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of DOC. JPMorgan Chase & Co. grew its holdings in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Healthpeak Properties by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust's stock valued at $371,168,000 after acquiring an additional 638,012 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the last quarter. Centersquare Investment Management LLC boosted its holdings in Healthpeak Properties by 3.7% in the fourth quarter. Centersquare Investment Management LLC now owns 11,215,516 shares of the real estate investment trust's stock valued at $227,339,000 after purchasing an additional 398,770 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Healthpeak Properties by 0.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust's stock valued at $205,810,000 after purchasing an additional 53,392 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Price Performance
Shares of DOC stock traded down $0.28 during mid-day trading on Monday, reaching $18.47. The company's stock had a trading volume of 897,646 shares, compared to its average volume of 4,890,156. The company has a market cap of $12.92 billion, a P/E ratio of 52.77, a PEG ratio of 2.17 and a beta of 1.02. The firm's 50-day moving average is $19.68 and its two-hundred day moving average is $20.67. Healthpeak Properties, Inc. has a 1-year low of $17.33 and a 1-year high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35.
Healthpeak Properties Announces Dividend
The firm also recently disclosed a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be paid a $0.1017 dividend. This represents a yield of 6.5%. The ex-dividend date is Thursday, April 17th. Healthpeak Properties's dividend payout ratio is currently 348.57%.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Wedbush reissued an "outperform" rating and set a $24.00 price objective on shares of Healthpeak Properties in a report on Friday, April 11th. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a report on Wednesday, January 15th. StockNews.com lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, April 14th. Robert W. Baird lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. Finally, Scotiabank cut their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Healthpeak Properties has a consensus rating of "Moderate Buy" and a consensus price target of $23.83.
Check Out Our Latest Stock Analysis on DOC
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
